| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |